SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis. - Njouendou AJ; Szarvas T; Tiofack AAZ; Kenfack RN; Tonouo PD; Ananga SN; Bell EHMD; Simo G; Hoheisel JD; Siveke JT; Lueong SS (Molecular cancer, 2023)